- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04043624
The Study of Perioperative Intravenous Infusion of Lidocaine on Postoperative Analgesia in Patients Undergoing Single-port Thoracoscopic
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The World Congress on Pain identified pain as the "fifth leading indicator of human life" after breathing, pulse, body temperature and blood pressure. Postoperative pain is an acute nociceptive pain caused by surgical trauma and is a complex stress response in the body, especially in 72 hours after surgery. Pain after thoracic surgery is a more severe type of surgery in various types of surgery.
Acute pain at the early stage of operation is not only an external signal of body injury, but also an independent factor inducing stress response and systemic inflammatory response syndrome (SIRS). Pain stimulus can also cause excessive release of catecholamine, damage of vascular endothelial cells and neutrophil aggregation, which can induce cytokine "waterfall" secretion. Stress, pain and inflammation induce and interact with each other, which seriously affects the early recovery of patients after operation. Timely and effective post-operative analgesia can not only alleviate patients'pain, but also avoid a series of stress reactions. It provides favorable conditions for the stability of patients' physiological function and recovery of their body after operation.
Although multimodal analgesia has largely replaced monotherapy with opioids, they are still the most commonly used drugs for postoperative pain. Lidocaine is an amide local anesthetic which when used intravenously demonstrates significant analgesic, anti-hyperalgesic and anti-inflammatory properties .
Intravenous infusion of lidocaine has a good effect on fibromyalgia, chronic neuropathic pain, opioid tolerance and other chronic pain, and can reduce postoperative acute pain. In the 1960s, Barlett et al. first published a study on the use of lidocaine intravenous infusion for postoperative analgesia.Since then, more and more researchers have begun to explore the use of lidocaine in the treatment of postoperative acute pain.In 2007, Kaba et al. selected patients who underwent colectomy as an experimental subject, and intravenously injected lidocaine during the perioperative period. The results showed that the pain of the experimental group was effectively relieved and the use of opioids was reduced. In 2008, Lauwick et al. used laparoscopic cholecystectomy as the experimental subject. The results showed that the dose of opioid analgesia in the lidocaine group was significantly lower than that in the control group, and the postoperative pain was effectively improved. In 2009, Yardeni et al. selected patients undergoing total hysterectomy as experimental subjects and intravenously injected lidocaine during the perioperative period. The results confirmed that the hemodynamics of the experimental group was more stable, the average dosage of anesthetics was reduced, and the pain was significantly improved.However, to date, there is no strong evidence for the effect of perioperative intravenous infusion of lidocaine in single-port thoracoscopic surgery, so we designed this study.
Type d'étude
Inscription (Anticipé)
Phase
- Phase 4
Contacts et emplacements
Lieux d'étude
-
-
Zhejiang
-
Hangzhou, Zhejiang, Chine, 310009
- Recrutement
- The Second Affiliated Hospital Zhejiang University School of Medicine
-
Contact:
- Jin Ma
- Numéro de téléphone: 86+18867539602
- E-mail: 1241370980@qq.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Patients undergoing single-port thoracoscopic with a left double lumen bronchial catheter
- Age ≧ 18 years old, ≦70 years old
- Temperature, white blood cells, and hemoglobin were normal before surgery
- Patient informed consent
Exclusion Criteria:
- Patients with a history of surgery within six months
- Patients with dysfunction of heart, liver, kidney, lung, pancreas or other important organs
- American Society of Anesthesiologists (ASA) physical Status classes ≧ Ⅲ
- Allergic to lidocaine
- Bradycardia (heart rate < 60 beats/min) or atrioventricular block
- Mental disorder
- Patients requiring a right double lumen bronchial catheter
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Lidocaine group
First group (lidocaine group) will include those who receive a intraoperative lidocaine infusion.Induction bolus dose of 1.5 mg/kg body weight ( 30 minutes before incision)followed by a continous lidocaine infusion of 2mg/kg/h,until 1 hours after skin closure.
|
regimen of lidocaine administration of 1.5 mg/kg, IV bolus, followed by continuous infusion at 2 mg/kg/h
|
|
Comparateur placebo: Saline group
The second group(saline group) will include those who receive a intraoperative placebo.The same dosage of saline was given according to the same method of administration in the lidocaine group.
|
IV bolus of saline, followed by continuous infusion of saline
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Postoperative pain score
Délai: Immediately postoperation
|
Using Visual Analogue Scales
|
Immediately postoperation
|
|
Postoperative pain score
Délai: 1 hour postoperation
|
Using Visual Analogue Scales
|
1 hour postoperation
|
|
Postoperative pain score
Délai: 4 hours postoperation
|
Using Visual Analogue Scales
|
4 hours postoperation
|
|
Postoperative pain score
Délai: 8 hours postoperation
|
Using Visual Analogue Scales
|
8 hours postoperation
|
|
Postoperative pain score
Délai: 24 hours postoperation
|
Using Visual Analogue Scales
|
24 hours postoperation
|
|
Postoperative pain score
Délai: 48 hours postoperation
|
Using Visual Analogue Scales
|
48 hours postoperation
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Opioid requirement
Délai: Immediately postoperation
|
The dosage of opioids was recorded
|
Immediately postoperation
|
|
Opioid requirement
Délai: 1 hour postoperation
|
The dosage of opioids was recorded
|
1 hour postoperation
|
|
Opioid requirement
Délai: 4 hours postoperation
|
The dosage of opioids was recorded
|
4 hours postoperation
|
|
Opioid requirement
Délai: 8 hours postoperation
|
The dosage of opioids was recorded
|
8 hours postoperation
|
|
Opioid requirement
Délai: 24 hours postoperation
|
The dosage of opioids was recorded
|
24 hours postoperation
|
|
Opioid requirement
Délai: 48 hours postoperation
|
The dosage of opioids was recorded
|
48 hours postoperation
|
|
Pressing times of PCIA postoperation
Délai: 48 hours postoperation
|
The pressing times of PCIA within 48 hours postoperation was recorded
|
48 hours postoperation
|
|
Occurrence of nausea and/or vomiting
Délai: 48 hours postoperation
|
The occurrence of nausea and vomiting within 48 hours postoperation was recorded
|
48 hours postoperation
|
|
Blood level of adrenaline
Délai: before induction
|
Perioperative blood level of adrenaline was recorded
|
before induction
|
|
Blood level of adrenaline
Délai: after incision
|
Perioperative blood level of adrenaline was recorded
|
after incision
|
|
Blood level of adrenaline
Délai: immediately after extubation
|
Perioperative blood level of adrenaline was recorded
|
immediately after extubation
|
|
Blood level of norepinephrine
Délai: before induction
|
Perioperative blood level of norepinephrine was recorded
|
before induction
|
|
Blood level of norepinephrine
Délai: after incision
|
Perioperative blood level of norepinephrine was recorded
|
after incision
|
|
Blood level of norepinephrine
Délai: immediately after extubation
|
Perioperative blood level of norepinephrine was recorded
|
immediately after extubation
|
|
Blood level of adrenocortical
Délai: before induction
|
Perioperative blood level of adrenocortical was recorded
|
before induction
|
|
Blood level of adrenocortical
Délai: after incision
|
Perioperative blood level of adrenocortical was recorded
|
after incision
|
|
Blood level of adrenocortical
Délai: immediately after extubation
|
Perioperative blood level of adrenocortical was recorded
|
immediately after extubation
|
|
Blood level of TNF-alpha
Délai: before induction
|
Perioperative blood level of TNF-alpha was recorded
|
before induction
|
|
Blood level of TNF-alpha
Délai: after incision
|
Perioperative blood level of TNF-alpha was recorded
|
after incision
|
|
Blood level of TNF-alpha
Délai: immediately after extubation
|
Perioperative blood level of TNF-alpha was recorded
|
immediately after extubation
|
|
Blood level of IL-6
Délai: before induction
|
Perioperative blood level of IL-6 was recorded
|
before induction
|
|
Blood level of IL-6
Délai: after incision
|
Perioperative blood level of IL-6 was recorded
|
after incision
|
|
Blood level of IL-6
Délai: immediately after extubation
|
Perioperative blood level of IL-6 was recorded
|
immediately after extubation
|
|
Blood level of IL-10
Délai: before induction
|
Perioperative blood level of IL-10 was recorded
|
before induction
|
|
Blood level of IL-10
Délai: after incision
|
Perioperative blood level of IL-10 was recorded
|
after incision
|
|
Blood level of IL-10
Délai: immediately after extubation
|
Perioperative blood level of IL-10 was recorded
|
immediately after extubation
|
|
Duration of hospital stay
Délai: from day of surgery until day of discharge from hospital
|
length of hospital stay (in days)
|
from day of surgery until day of discharge from hospital
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chaise d'étude: Congcong Chen, Second Affiliated Hospital, School of Medicine, Zhejiang University
Publications et liens utiles
Publications générales
- Lauwick S, Kim DJ, Michelagnoli G, Mistraletti G, Feldman L, Fried G, Carli F. Intraoperative infusion of lidocaine reduces postoperative fentanyl requirements in patients undergoing laparoscopic cholecystectomy. Can J Anaesth. 2008 Nov;55(11):754-60. doi: 10.1007/BF03016348.
- Kaba A, Laurent SR, Detroz BJ, Sessler DI, Durieux ME, Lamy ML, Joris JL. Intravenous lidocaine infusion facilitates acute rehabilitation after laparoscopic colectomy. Anesthesiology. 2007 Jan;106(1):11-8; discussion 5-6. doi: 10.1097/00000542-200701000-00007.
- Koppert W, Weigand M, Neumann F, Sittl R, Schuettler J, Schmelz M, Hering W. Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg. 2004 Apr;98(4):1050-1055. doi: 10.1213/01.ANE.0000104582.71710.EE.
- Yardeni IZ, Beilin B, Mayburd E, Levinson Y, Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg. 2009 Nov;109(5):1464-9. doi: 10.1213/ANE.0b013e3181bab1bd.
- Schafranski MD, Malucelli T, Machado F, Takeshi H, Kaiber F, Schmidt C, Harth F. Intravenous lidocaine for fibromyalgia syndrome: an open trial. Clin Rheumatol. 2009 Jul;28(7):853-5. doi: 10.1007/s10067-009-1137-8. Epub 2009 Mar 5.
- Challapalli V, Tremont-Lukats IW, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD003345. doi: 10.1002/14651858.CD003345.pub2.
- Buchanan DD, J MacIvor F. A role for intravenous lidocaine in severe cancer-related neuropathic pain at the end-of-life. Support Care Cancer. 2010 Jul;18(7):899-901. doi: 10.1007/s00520-010-0864-3. Epub 2010 Apr 29.
- Sharma S, Rajagopal MR, Palat G, Singh C, Haji AG, Jain D. A phase II pilot study to evaluate use of intravenous lidocaine for opioid-refractory pain in cancer patients. J Pain Symptom Manage. 2009 Jan;37(1):85-93. doi: 10.1016/j.jpainsymman.2007.12.023. Epub 2008 Jul 2.
- Eriksson AS, Sinclair R, Cassuto J, Thomsen P. Influence of lidocaine on leukocyte function in the surgical wound. Anesthesiology. 1992 Jul;77(1):74-8. doi: 10.1097/00000542-199207000-00011.
- Feng G, Liu S, Wang GL, Liu GJ. Lidocaine attenuates lipopolysaccharide-induced acute lung injury through inhibiting NF-kappaB activation. Pharmacology. 2008;81(1):32-40. doi: 10.1159/000107792. Epub 2007 Sep 4.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Anticipé)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
- Effets physiologiques des médicaments
- Mécanismes moléculaires de l'action pharmacologique
- Agents anti-arythmie
- Dépresseurs du système nerveux central
- Agents du système nerveux périphérique
- Agents du système sensoriel
- Anesthésiques
- Modulateurs de transport membranaire
- Anesthésiques locaux
- Bloqueurs de canaux sodiques voltage-dépendants
- Bloqueurs des canaux sodiques
- Lidocaïne
Autres numéros d'identification d'étude
- 2019-084
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .